Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia

CONCLUSION: Increased expression of ICOS predicted poor outcomes, and ICOS/PD-1 was the optimal combination of ICs to predict outcomes in patients with AML, which might be a potential immune biomarker for designing novel AML therapy.PMID:38615511 | DOI:10.1016/j.imbio.2024.152804

Source: Immunobiology - April 14, 2024 Category: Allergy & Immunology Authors: Shiyi Pan Qinghua Cai Yiqiong Wei Haifeng Tang Yuping Zhang Wei Zhou Tingfen Deng Wenjian Mo Shunqing Wang Caixia Wang Cunte Chen Source Type: research